33 results
PRE 14A
LBPH
Longboard Pharmaceuticals, Inc.
28 Mar 24
Preliminary proxy
4:36pm
served as Chief Strategy Officer and Group Executive Vice President, Global Business Development for Teva Pharmaceutical Industries, Ltd. from 2013 … Strategy from June 2018 to March 2019, and Senior Vice President of the Europe Region from June 2015 to May 2018. Dr. Le Goff worked in the policy community
S-3ASR
LBPH
Longboard Pharmaceuticals, Inc.
12 Mar 24
Automatic shelf registration
4:45pm
a significant return, if any, on our investment of these net proceeds, it could compromise our ability to pursue our growth strategy and adversely
8-K
EX-99.2
9qp75mzjh224myf3 1tv
12 Mar 24
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
4:10pm
424B5
kfjanw
4 Jan 24
Prospectus supplement for primary offering
4:48pm
424B5
9z7iva69e9vmwm22v5
2 Jan 24
Prospectus supplement for primary offering
4:54pm
424B5
bslvb378y poa
4 Aug 23
Prospectus supplement for primary offering
4:20pm
8-K
EX-99.1
fqvsi5lu59yppb44yc6
5 Dec 22
Regulation FD Disclosure
8:45am
S-3
gnfba
30 Sep 22
Shelf registration
4:11pm
DEF 14A
3yb6ws b2jq
13 Apr 22
Definitive proxy
4:15pm